Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Imaging (MI), Molecular Therapeutics (MT) and Population Studies and Disparities Research (PSDR).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

The Latest From Karmanos Cancer Institute

News

Shari Ferber Kaufman joins Karmanos Cancer Institute Board of Directors

The Barbara Ann Karmanos Cancer Institute is pleased to announce the election of Shari Ferber Kaufman to its board of directors. Kaufman will serve...

Read More

Karmanos awarded President's Trophy for second year in a row by McLaren Health Care

For the second year in a row, the Barbara Ann Karmanos Cancer Institute has been named the recipient of the President’s Trophy by the McLaren Heal...

Read More

Introducing the new Karmanos.org

The Barbara Ann Karmanos Cancer Institute is excited to announce the launch of the new and improved Karmanos.org website. The new website has easy...

Read More